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 This industry-level study examines the impact of foreign country factors like market size, 
technological strength, and science and engineering (S&E) capability on the conduct of U.S. 
overseas R&D during the 1991-2002 period. We find that while overseas markets primarily 
predict the entry of U.S. R&D, the S&E knowledge base of nations critically determines the level 
and sophistication of U.S. foreign subsidiaries’ innovative activity. We also find important inter-
industry differences: U.S. electrical, electronics, computers, and communication industries are 
strongly drawn towards overseas S&E capability; industries including machinery, automobiles, 
and transport equipment are primarily attracted by the technological strength of foreign nations; 
U.S. R&D in chemicals mostly follows overseas markets.        
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1.0 Introduction 
Around the world innovation is now recognized as a prime source of national competitive 
advantage.  Many nations have focused policy initiatives on strengthening their innovative 
capacities and success is becoming apparent. As a result, the answer to the question: “who will 
own the technologies of the future?” is becoming less obvious, and the globalization of U.S.-
owned innovative activity is a subject of some anxiety.  To judge by media reports, U.S. firms are 
performing an increasing portion of their innovation activities in foreign “independent R&D 
centers” (see for example, New York Times 2004; Wall Street Journal 2004).  In that these 
laboratories are not necessarily tied to the geography of product demand, our classic 
understanding of forces driving global R&D needs updating.  Vernon’s “product life cycle” 
hypothesis (1966) that American R&D overseas develops around its foreign markets may well 
account for a diminishing share of the “globalization of U.S. R&D” story. 
 “Globalization” of innovation variously refers to innovation by overseas subsidiaries, or 
the sourcing of R&D through alliances and joint ventures with foreign companies or universities, 
or the exploitation of foreign technologies through patents and licenses (Archibugi & Michie 
1997).  In this paper we seek to investigate factors that determine the initiation and growth of 
innovative activity by foreign subsidiaries of U.S.-owned large firms.  Specifically, we look for 
the influence of a host country’s scientific and technological capability on the conduct of U.S. 
multinational R&D in that country.  Inter-industry differences in the explanatory power of these 
factors are also investigated. To put our empirical contribution into perspective, we do not here 
treat the nature of the product, firm, or markets as explanations for the overseas conduct of U.S. 
R&D. Such approaches were originally pursued by Vernon (1966, 1979), Horst (1972), Mansfield 
et al (1979), and have been developed more recently by others (Caves 1996 presents a review). 
 Our panel data comprise annual industry-level patenting and R&D expenditure records 
(the outcome variables of our study) of the majority-owned affiliates of U.S. multinational 
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corporations (“MNC” for short) in 45 foreign nations where they have a significant presence. The 
principal feature of our analysis is the attempt to move away from the comparative cost doctrine 
and market-based theories, and instead concentrate on technological strength and S&E capability 
of foreign nations as explanations of U.S. innovative activity in their locales. Further, we 
distinguish the effect of our explanatory variables on (a) the probability of U.S. subsidiary 
innovation activities, and (b) the intensity of innovation by the subsidiaries on their shores. Set in 
a period of intense corporate dynamism and change (1991-2002), our study also addresses inter-
industry differences among foreign markets, industrial strength, and S&E capabilities as 
predictors of U.S. innovation abroad.  
 In investigating a topic as complex and important as the innovation location decision of 
industries, we have encountered a large volume of pertinent theoretical and empirical literature. 
The next section presents a brief survey of the antecedents of our effort. We bring together 
publicly available data from the United States Patents and Trademarks Office (USPTO), the 
Bureau of Economic Analysis (BEA) and the National Science Foundation (NSF) for our 
empirical analysis. A following section explains this and the operationalization of our constructs 
into variables and hypotheses. Description of the statistical models employed and results obtained 
are dealt with in the fourth section. A fifth and final section discusses implications of our research 
for innovation and public policy.  
2.0 Literature Review 
Here, we offer an account of the changing role of foreign subsidiaries in the innovation activities 
of multinational corporations. Our review is selective, with an effort to capture broad trends in the 
globalization of technology as mapped by representative literature over the last five decades.   
2.1 Foreign R&D as customization and modification 
 Foreign R&D of multinational companies was first understood as supporting foreign 
markets. This pattern is apparent in Vernon’s (1966) product life cycle hypothesis which argued 
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that MNCs’ foreign laboratories mainly concentrate their work in the development end of the 
R&D spectrum, with a mandate to customize products and processes for local tastes and 
requirements. In contrast, sophisticated research and major product innovations stayed home, 
inseparably bound to headquarters by requirements for swift and frequent communication 
between researchers, sales and customers. 2 
 According to Vernon’s initial formulation, the need for close communication and 
cooperation between producers, consumers, suppliers and competitors is critical in the early 
stages of a product’s lifecycle, due to uncertainty regarding the dimensions of the market (Vernon 
1966, p. 195).  As products matured, they would be more price sensitive, subject to greater 
competitive pressures and would be manufactured more cheaply abroad. Such products were 
mostly standardized, and the need for any significant R&D to follow manufacturing was not 
considered.  In a second paper, Vernon recognized that routine aspects of development could be 
spun off to distant locations to reduce development costs and appease local governments (Vernon 
1979, pp. 262-3). Today we might interpret Vernon’s analysis of the product development stages 
in international location decisions as supporting the theme that early stage innovation is best 
served by locating close to headquarters and home-country markets.  
 Much of traditional economic analysis aligns with Vernon’s hypothesis. Caves (1996) for 
example, notes that effective R&D requires a continuous interchange of information with 
manufacturing and marketing to ensure that research is directed at significant economic problems 
and solutions are market-worthy. Because R&D plays a strategic role, research operations should 
also be in close contact with top corporate management.  Requirements for frequent 
                                                     
2 Most of the surveyed studies here model R&D location as a matter of the firm’s choice between 
home- and foreign country location factors. In contrast, our model addresses determinants of U.S. 
industry’s innovation activities in alternate foreign locations. Yet many of the results from studies 
reviewed here are pertinent to our exercise. 
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communication and interchange along with scale economies of the R&D function call for the 
centralization of R&D activities at company headquarters. Hence, despite the “centrifugal pull of 
manufacturing facilities dispersed to serve far-flung markets,…the agglomerative tendencies for 
research to remain at corporate headquarters remains strong”  (p 164).  
 Empirical studies of patenting and surveys of MNCs during the 1980s also found that 
sophisticated research tends to stay at home in a globalizing world, and that what does go abroad 
is mostly development. Patel and Pavitt (1991) investigated the patenting activities of 686 of the 
world’s largest manufacturing firms and report that a rather miniscule percentage (3.2%) of the 
technology activities of U.S.-based firms were conducted overseas (1981-1986). Hence, in 
comparison to manufacturing, technological innovation represented an anomalous case of “non-
globalization” (Patel & Pavitt 1991). Mansfield et al (1979) surveyed 55 large U.S. firms (for the 
1960-1974 period) to report that foreign R&D comprised about a tenth of their overall R&D 
expenditures.  Further, the authors’ note (p. 188): “[A]bout three-fourths of these firms’ overseas 
R and D expenditures are aimed at product or process improvements and modifications, not at 
entirely new processes or products.  This percentage is much higher than for all domestic R and 
D” (p. 193).  This finding supports the idea that “overseas laboratories are closely geared to the 
special design needs of foreign markets (and the firm’s overseas plants). . .”  
2.2 Foreign R&D includes listening posts 
 Empirical studies during the late 1980s and early 90s reported an increase in the share of 
R&D and patents attributable to overseas subsidiaries of U.S. firms. Dunning (1992) found an 
increase in the share of patents assigned to U.S. firms abroad from 4.2% (during 1969-1972) to 
7.4% (during 1983-1986). A later study by Pavitt and Patel (1998) found that about 8% of patents 
assigned to 128 of America’s largest firms (during 1992-1996) were assigned to their foreign 
subsidiaries.  
 Paralleling the apparent increase, was the observation that customizing products for local 
markets does not completely account for foreign R&D. Mansfield et al (1979) reported evidence 
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for basic research (albeit limited) overseas. Dunning (1994) explained that MNC R&D overseas 
can encompass the following activities: 
(i) Product, material or process adaptations or improvements. 
(ii) Basic materials or product research – on immobile subjects such as tea plantations, 
oil refineries, bauxite mines or agricultural productivity 
(iii) Rationalized research, i.e. all research on a particular topic conducted in one location 
(iv) To acquire or gain an insight into foreign innovating activities, i.e. learning and 
building firm research capability (p. 75-76). 
 Type i represented classic overseas R&D supporting overseas markets.  Type ii was an 
elaboration, more sophisticated applied research forced to locate abroad due to the immobility of 
natural resources or the subject of research.  Type iii introduced the possibility of high end 
innovation outside the home country, and according to Dunning, such research was restricted to 
the triad: U.S., Europe and Japan. Type iv might be termed “listening post” R&D.  This 
recognized the high level R&D capability abroad and the need for firms to learn from it.  The 
rationale was that technical knowledge will be picked up abroad and transferred back to the home 
base. Type i was the most prevalent, while types ii and iv were the fastest growing (Dunning 
1994).   This framework advanced understanding of overseas R&D by expanding discussion from 
local market adaptation to listening post functions in recognition of high levels of technological 
capability in Europe and Japan. 
 The most sophisticated innovative role afforded to foreign subsidiaries in this line of 
thinking recognized that firms had adopted a global approach not only to applying their 
knowledge in foreign operations, but to enhancing their home innovation capabilities (during the 
late 1990s). Where multinational firms seek a foreign R&D presence to support their overseas 
manufacturing facilities or to adapt standard products to local demand conditions, the 
arrangement has been called “home-base exploiting” R&D (Kuemmerle 1997).  Here information 
flows from the central firm’s R&D capacity at home to the foreign subsidiary. In a second type, 
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“home-base augmenting” R&D, the foreign facility is established to tap the knowledge of foreign 
competitors and universities.  In this case, knowledge is absorbed from the local community; new 
knowledge is created and transferred to the company’s central R&D.  Instead of building on their 
existing technological capabilities and seeking to extend these to foreign circumstances, firms 
aim to use local knowledge bases to develop new capabilities at home (Kuemmerle 1997).  This 
representation recognizes a more sophisticated level of knowledge located abroad than ever 
before, yet the home remains dominant in that both home-base exploiting and home-base 
augmenting R&D are defined relative to and indeed serve the needs of the home base. 
2.3 Foreign R&D emerging as a source of innovation 
 In both the adaptation/modification and the listening post models, overseas R&D sites 
were auxiliary outposts, subservient to home R&D laboratories.  Although we might detect hints 
of equality in overseas R&D labs, for example in Dunning’s level iii, the models’ emphasis lay 
elsewhere.  These models are no longer adequate as MNCs are now able to seek innovation 
abroad and not just from Europe or Japan but also from Asian countries. The Economist 
Intelligence Unit (EIU 2004) surveyed 104 senior corporate executives who reported that MNCs 
now seek to establish and manage “global research networks” of geographically dispersed units 
that contribute more or less equally to the company’s research enterprise.  Recent studies suggest 
the possibility of a truly networked corporation in which responsibility for innovation is globally 
dispersed and an important role in the innovative process is played by the subsidiaries in 
accessing, sharing, and creating new knowledge (Almeida & Phene 2004).   
3.0 Hypotheses, Variables and Data 
We propose that the emerging recognition of advanced innovative capability in MNC foreign 
laboratories requires a fresh examination of the determinants of foreign R&D.  It seems 
implausible that the location decisions for more sophisticated foreign R&D functions are driven 
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by the market-based factors classically associated with foreign R&D location.  We therefore seek 
to explore the emergence and growth of simple and more sophisticated foreign R&D function.   
3.1 Dependent variables 
 Since we seek to explain the innovative activity of U.S. overseas subsidiaries, R&D 
expenditures and patents of American industries abroad are the outcome variables in our study.  
Our treatment of these variables is somewhat non-standard.  The relation between the R&D input 
variable and the patent output variable has been widely studied, and the two are known to 
correlate (Schmookler 1967, and Hall, Grilliches & Hausman 1986 are seminal works).  U.S. 
firms that spend more on R&D tend to produce more patents than other U.S firms in their 
industry.  Nevertheless, in this study we focus on the difference between these two measures.  
We are interested in the changing composition of foreign R&D expenditure.  Mansfield et 
al. (1979) established through a survey that R&D expenditure in subsidiaries is heavily weighted 
towards development compared to the research emphasis of domestic corporate R&D.  Here we 
probe growth in non-development activity as a component of foreign subsidiary R&D.  Absent a 
survey, movement in R&D expenditure data will not reveal increased sophistication in the 
composition of R&D.  However, we argue that within the context of foreign subsidiary R&D, 
U.S. patenting signals the presence of more sophisticated inventive activity.  Note that Mansfield 
et al. concluded using R&D expenditure data that U.S. foreign R&D was more substantial than 
Pavitt found using patent data, and that this is consistent with our argument that USPTO patenting 
indicates a sophisticated component of foreign R&D and is therefore more limited in extent than 
R&D as a whole.  For a firm to incur the cost of a U.S. patent for an invention originating in a 
foreign subsidiary implies that the invention is both new to the world and likely to be used in the 
U.S. market.  Product modifications tailored to local foreign markets are unlikely to justify the 
expense of protection in the U.S. market bestowed by a U.S. patent. Patents require a distinct 
element of novelty, which means that “listening post” or learning activities are unlikely to 
produce them.  Our contention then is that in the context of foreign subsidiary R&D, U.S. 
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patenting represents a more innovative component of an activity that is fully encompassed by 
R&D expenditure.   
We also distinguish between the initiation of foreign R&D and its growth.  That is, we 
model the probability of there being non-zero R&D expenditure (or patenting), as well as 
modeling the amount of R&D expenditure (or patenting), conditional on the measure being non-
zero.  The first decision to locate an operation in a country is made under conditions of greater 
risk and uncertainty than subsequent decisions to expand the operation. Vernon (1979) noted the 
“self-reinforcing” nature of foreign operations, that after the first decision to go abroad, 
subsequent decisions became easier and quicker as companies “felt at ease over a wider portion 
of the earth’s surface.”  We hypothesize that the decision to initiate R&D in a country is likely to 
be related to the need to modify products for a market, and that the decision to develop a 
worldwide network of more or less equal R&D labs comes later and is made against a 
background of established foreign R&D operations and is therefore associated with growth, not 
initiation of R&D.  Therefore the factors associated with the probability of activity abroad may 
well differ from the factors associated with magnitude, and we explore this in our modeling. 
3.2 Independent variables and hypotheses 
 Our first independent variable is overseas sales.  That the R&D of multinational 
enterprises follows overseas sales has been established, enabling us to expect a positive 
relationship between the size of overseas markets and U.S. subsidiary R&D activity that will 
manifest in the R&D-sales relationship.   
 Our second independent variable is national output of scientific and engineering articles.  
We use S&E articles as an indicator of productive, world class scientific talent in a nation’s 
public sector.  Papers indicate the tacit knowledge and skills possessed by their authors (Hicks 
1995), and so we argue that a nation’s scientific publication oeuvre provides an indicator of its 
scientific and technical human capital.  Unlike money spent on universities or number of PhD 
graduates, number of papers is a selective measure in which unproductive people and resources 
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are invisible.  In a sense, the measure reflects the success of education, research support, 
institutional development and other policies to enhance the research base of a national system of 
innovation.  The measure also has the virtue of imposing an international quality standard.  When 
multinational firms search for expertise, one might assume that only world class expertise is of 
interest.  The papers were counted in Thomson’s Science Citation Index, which has frequently 
been faulted for under-representing non-Anglo Saxon research.  Thus for most countries in the 
world, a count of their papers in this database represents their most internationally competitive 
science and technology, with international competitiveness defined by peer reviewers often 
located in the U.S.   
We hypothesize that public sector S&T capability attracts multinational global R&D 
activity of the more sophisticated sort.  We do not argue that global R&D is initially attracted by 
S&T capability; rather we expect that market factors predominate in the early stages of 
globalizing R&D.  However, we do expect that once an R&D base has been established, growth 
of innovative global R&D (indicated by patenting rather than R&D spending) requires indigenous 
world class scientific talent.  We cite in support of our hypothesis the EIU survey, which 
concluded that “expertise is the top attraction for globalised research” (EIU, 2004, p. 2).  Our 
S&E paper variable measures the amount of world class scientific expertise in a country. 
Our third independent variable is the number of USPTO patents invented in the country 
and not assigned to US companies which we use to measure the technological strength of a 
nation.  The patent variables, national and U.S. multinational, are categorized the same way, so a 
specific match between company and national technical strengths is obtained.  Like the paper 
variable, the national patent variable indicates innovation that meets a certain internationally 
benchmarked minimum threshold of inventiveness and significance.  Because “listening post” 
R&D must have something worthwhile to listen to, we expect a positive relationship between a 
foreign country’s technological strength and the extent of U.S. R&D carried out therein.   
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Like the paper variable, the national patent variable reflects the amount of world class 
technical expertise in a country.  However, in this case the experts are employed by other firms, 
perhaps competitors.  Competition from technologically strong local firms can under certain 
circumstances deter subsidiary innovation activities.3  Therefore, the effect of national patenting 
is not entirely clear.  However, the presence in our models of both the national patent and paper 
variables will have the advantage of distinguishing between the effects of public sector, general, 
scientific expertise and private sector, targeted, technical expertise. 
3.3 Data 
 Since we intend to explain the R&D location decisions of American industry, only 
majority-owned foreign affiliates or subsidiaries in which the combined ownership of all U.S. 
parents exceeds 50 percent are included in our analysis.  Our sample was constructed from three 
publicly available data sources. First, industry-level statistics on the international activity of U.S. 
multinational companies are produced annually by the Bureau of Economic Analysis (BEA). This 
includes industry-level information on the sales of majority-owned subsidiaries in various foreign 
countries and their R&D expenditures. Since the BEA industry classifications were not consistent 
across panels, we recoded the numbers to comply with one of eight broad industry classifications. 
Accordingly we have annual local sales and R&D data for American firms for the following 
industries between 1991 and 2002: chemicals; electrical, electronics, computers, and 
telecommunications; food; industrial equipment and machinery; oil, minerals and natural gas; 
primary and fabricated metals; automobile, air, and transport equipment. An eighth “others” 
category accounts for leftovers.    
 Second, patents assigned to all overseas inventors were collected from the United States 
Patents and Trademarks Office (USPTO). From this population of patents originating abroad, we 
identified patents assigned to U.S. corporations including majority-owned subsidiaries.  The 
                                                     
3 Especially where the country environment does not support rigorous enforcement of IP rights 
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residual is the number of foreign-owned patents which indicates the technological strength of 
countries.  It is possible that the residual includes USPTO patents assigned to subsidiaries of other 
foreign country firms. If this were the case, what we label the “technology strength” of foreign 
nations could be driven by non-US multinationals. For example, China’s measure of 
technological strength in any industry could be influenced by the USPTO patents of European or 
Japanese –owned Chinese subsidiaries.  To confirm that this is not the case, we examined the 
national origins of the top-20 patentees in 10 different countries (including China). The exercise 
revealed that the weight of non-US, non-local patents for any given country is negligible.  To 
account for the fact that a patent can have inventors from multiple countries, we calculated 
fractional counts for non-U.S. owned patents such that if a patent has two Japanese inventors and 
one U.K. inventor, two-thirds of the patent is assigned to Japan, and the remaining third to the 
U.K.  We then matched and merged the two variables (patents assigned to majority owned U.S. 
subsidiaries, and patents assigned to foreign countries) with the BEA variables by country, 
technology class, and year (for the years 1991 and 2002) after establishing a concordance 
between the IPC technology class of patents and eight broad industry sectors. 
 Finally, data on science and engineering publications of various countries were drawn 
from the National Science Foundation’s annual Science and Engineering Indicators. This 
information is available from the year 1988 through 2001 and is based on Thomson’s Science 
Citation Index which covers all scientific fields for primarily English language journals that are 
well cited. Like our patents, the article counts are based on fractional assignments such that an 
article with two authors from different countries is counted as one-half of an article for each 
country.  The patent and S&E article variables differ, as exemplified by the subject coverage of 
the articles.  In 2001, only 14.5% of Western European and 8.1% of Asian S&E articles were 
from engineering and technology fields.  The rest were from scientific fields including physics, 
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chemistry, biology, clinical, and biomedical fields.4  Note that these classifications could not be 
matched to industry sectors and so our publishing variable does not vary by sector. 
 Our final data set contains observations from the years 1991 through 2002 for the 8 
industry classes of 45 foreign countries on (a) the number of USPTO patents assigned to U.S. 
subsidiaries and invented in each country (b) R&D expenditures of U.S. subsidiaries in each 
country (c) local sales of the U.S. affiliates, and (d) patents assigned to foreign country firms.  For 
each year through 2001 and country (but not industry) we have science and technology 
publication output.  A country-industry observation for a given year constitutes a unique 
observation, of which we have 1817.  This lower than expected number is because the BEA data 
does not provide information on each of the 8 industry sectors for all 45 countries and 12 years of 
study, plausibly due to the absence of significant industry activity for the missing observations.5 
This makes our dataset an “unbalanced panel.”  
TABLE 1 HERE 
 Table 1 lists country-level statistics for the five variables, aggregated over the period of 
our study as well as for the first and last years, from which a large increase in the overseas 
activity of U.S. firms is apparent.  
  
                                                     
4 For Asian countries the respective percentages are Physics (19.8), Chemistry (18.2), 
Biology(5.5), Clinical(22.2) and Biomedical research(11.9). For West European countries, the 
numbers are: Physics (12.7), Chemistry (11.5), Biology(6.6), Clinical(32) and Biomedical 
research(14).    
5 Data on all variables for Poland and Hungary for example, were available only for the years 
2000 and 2001; U.S. industrial activity was observed in only a few of the 8 industry sectors in a 
majority of South American and African countries.    
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4.0 Model and Results 
This section models the impact of foreign country markets, scientific capability, and industry 
innovation capabilities on (a) establishing U.S. corporate research where none existed, and (b) the 
extent of U.S. R&D activity, once established.6 In the R&D expenditures of overseas subsidiaries 
and the number of patents assigned to them, we have two distinct measures of U.S. innovative 
activity abroad. The two variables indicate both the existence and magnitude of U.S. innovative 
activity overseas. 41% and 36% of our 1,817 country-industry-year observations have zero 
number of patents and R&D expenditures respectively.  
4.1 Model specification 
 We hypothesize that the variables of our study are related per the following equation, 
where ][ ,, tkiyE  is the conditional expected value of U.S.-owned foreign subsidiary R&D 
expenditures (or patents) y, for country i, in technology class k and year t. The expected value of 
the dependent variable takes on probabilistic values when establishment of activity is estimated 
and integer values when extent conditional on establishment is estimated.  
kkktttitkitkitki xxXxxxyE 6541,331,,221,,110,, 4][ γαβββββ ∑+∑+′++++= −−−    (1) 
Here, x1 is local sales and x2 is the number of country i’s own patents in technology class k for the 
year t-1 and x3 is the number of science and technology articles. x4 and x5 express time and 
technology class dummies. By lagging regressors by a year, we also allow for some time for their 
                                                     
6 Strictly, a country-industry might report zero patents/R&D expenditures in time periods 
following years with non-zero, positive values for these variables. However, this being the case 
for a small portion of our observations, we use the term “initiation” to represent a nonzero 
probability of R&D/patents and “growth” to capture the magnitude of positive R&D/patents. 
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effect to bear fruit (patents).7,8 4X ′  expresses a vector of region-specific effects that do not vary 
with time or technology class. We used 5 regional (Europe, Japan, Rest of Asia, South America 
and Others) instead of 45 country dummies to minimize the number of regressors.9 This controls 
for unobserved heterogeneity among regions and roughly simulates a “fixed effects” panel model, 
where region and technology-specific factors potentially correlated with the included regressors 
are accounted for as sources of identification by the various dummies. 
 Since R&D expenditures are integers and patents are whole number counts, we specify 
two different models to explain their determinants. The relationship between the explanatory 
variables in (1) and R&D expenditures of American overseas subsidiaries is estimated using a 
Tobit specification. The Tobit model has an advantage in that its coefficients can be easily 
disaggregated to determine the effect of a change in the explanatory variable on changes in the 
probability of having non-zero R&D as well as the size of R&D (McDonald and Moffit 1980). 
                                                     
7 This also conveniently allows us to utilize the maximum range of our dataset since information 
on one of the regressors (S&E articles) are available only through 2001, while patent data is 
updated to 2002. Our unreported estimations of contemporaneous regressors as well as two and 
three-year lagged values yield similar results. 
8 Assuming a lagged structure mitigates also the potential problem of the regressors being 
endogenously related to the explained variables.  
9 Reason for including broad region instead of country dummies is that statistical software used to 
estimate likelihood functions are sensitive to the number of variables. The maximum likelihood 
estimations failed to converge on the inclusion of country-specific dummies. However we believe 
that our classification scheme of countries minimizes inter-country variations within regions. We 
confirmed this by comparing the results of OLS regressions with both the full set of country and 
region–specific dummies.    
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From the decomposition, one effect works by changing the probability that R&D will be 
undertaken and the second by changing the conditional mean of R&D expenditures, given that 
R&D is observed (greater than zero).  While the first is about the effect of a unit change in any of 
the regressors on the probability of having any (positive) level of R&D, the second is about the 
effect of a unit change in any of the regressors on the level of R&D (once it is positive). 
 Next, we test the relationship between the explanatory variables of (1) and patents of 
American overseas subsidiaries by employing a variation of the zero-inflated Poisson (ZIP) 
regression model originally proposed by Lambert (1992) and developed by Greene (1994). Like 
Tobit, this specification appeals to our application because it allows us to estimate the impact of 
explanatory variables on (a) the probability of U.S. patenting, and (b) the number of subsidiary 
patents once the activity has begun. In other words, the model allows us to test a process in which 
the factors that determine zero or positive U.S. overseas patents are qualitatively different from 
those determining the magnitude of patents once the activity has been established.        
 The Poisson specification however is rather unrealistic as it imposes (or rather assumes) 
the restriction that the variance of the data is equal to its (conditional) mean. When this is not true 
and the variance far exceeds the mean as in the case of our data, over-dispersion can result in the 
Poisson under-predicting outcomes at the “tails” of the distribution.10 Despite the fact that we 
account for the large number of zeros by estimating a model that assumes different underlying 
processes for the zero and positive outcomes, over-dispersion among positive patent counts 
suggests that the negative-binomial model (negbin), is more appropriate.  
 The negbin model is a more general version of the Poisson model with less strict 
assumptions and is widely used in estimations using patent and publication counts as the 
dependent variable (cf. Hausman et al 1984). Substituting the Poisson with a negative binomial 
distribution for our specification yields a “zero-inflated negative binomial model” (ZINB). The 
                                                     
10 for our data, mean = 35.63 and Variance = 7815.6 
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logistic portion of the zero-inflated negative binomial yields the conditional expectation of the 
probability of y falling into the zero group, or ]|0Pr[ ,, Xy tki =  and the negative binomial part 
estimates ,...3,2,1],|Pr[ ,, == nXny tki or the conditional expectation of y taking on any 
positive value.   
4.2 Results 
 Table 2 presents results of the Tobit and zero-inflated negative binomial regression 
models. Columns 1-3 are Tobit estimates that explain the R&D expenditures of U.S.-owned 
overseas subsidiaries. The first column presents standard Tobit coefficients which can be 
interpreted as the effect of a unit change in regressors on the expected value of an R&D 
expenditures latent variable.  Column 2 presents the effects of a unit change in explanatory 
variables on the conditional mean of R&D expenditures, given that it is observed (greater than 
zero); a third column lists the probability that R&D will be undertaken for unit changes of the 
explanatory variables.  Local sales of overseas subsidiaries directly influence both the probability 
and level of R&D expenditures of the industry. Foreign country patents, as well as S&E papers 
affect the probability of R&D only negligibly. The latter has a marginally higher impact on the 
level of R&D, on controlling for sales and other factors.11   
   The ZINB model can be interpreted as a “count-hurdle” model where the logit function 
estimates impacts of the various explanatory variables in overcoming the patenting hurdle (this 
part treats USPAT as a dichotomous variable set to 1 for a positive number of patents and 0 when 
no patents are observed) and the negative binomial estimates the weight of the variables on the 
number of patents once the threshold is crossed (this part treats the conditional number of patents 
                                                     
11 To clarify trends in the impact of regressors, we also examined their effects across four 3-year 
windows spanning the years 1991 through 2002. We found no evidence for the changing effect of 
explanatory variables over time. 
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above zero as a dependent variable).12 That the estimated effects of such a model are fair 
predictors of the actual distribution of patents is evidenced from the plot of predicted v/s observed 
probabilities in Figure 1. 
FIGURE 1 HERE 
  The fourth column of Table 2 produces zero-inflated probabilities for the patent “hurdle”. 
These can be interpreted like the normal logistic coefficients (which yield logged odds), the 
difference being that these predict zeros.  Hence, coefficients with negative signage mean that 
changes in the related variable are inversely related to the likelihood of belonging to the zero-
patent group.  For example, an increase in the local sales of U.S. overseas industry over a given 
year makes it less likely for it to exist in the “zero-patent” state in the next year.13  So also, a 
country with U.S. patents in a given industry is more likely to see U.S. owned subsidiaries in that 
industry engaged in patenting.  S&E capability of foreign countries appears to have negligible 
influence on the probability of U.S. industry patenting, after controlling for the effect of other 
regressors. 
TABLE 2 HERE 
                                                     
















1 where ( )ii Xyf |1  and ( )ii Xyf |2  are the 
probability density functions of the zero-inflated negative binomial and zero-inflated Poisson 
respectively. In our case, it yielded a value of 10.79 with (Pr> Z =  0.00) justifying our choice of 
the ZINB over ZIP. 
13 We confirmed the broad results of our models by ensuring that they were not sensitive to 
plausible alternative specifications and that the independent variables were not seriously collinear 
by estimating Variance Inflation Factors for baseline OLS regressions. They were well within the 
permissible bounds (in the range of 1.2 to 2.5).     
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 The fifth column of Table 2 presents the impact estimates of the explanatory variables on 
the level of U.S. industry patents, given that they are already engaged in that activity. The neg-bin 
coefficients are presented as incidence rate ratios (IRR) for ease of interpretation. The coefficient 
on SALES (1.08) indicates that a unit (billion $) increase in the annual local sales can be expected 
to yield an 8% increase in the number of patents in the U.S. subsidiary’s industry (subject to the 
condition that it has already started patenting).  A unit increase (1 unit = 1,000 S&E articles) in 
the annual S&E publication output of a country for the same period is expected to increase 
American patents in the country by 5%, holding constant the effect of other variables.  Because of 
the disparate nature of units, much meaning cannot be derived from a direct comparison of the 
estimated magnitude of coefficients. Normalized coefficients14 and t-statistics (presented in 
parenthesis under the coefficients), confirm the relatively large and positive effect of the scientific 
knowledge pool of countries on the intensity of American patenting.15  
4.3 Inter-industry differences  
 The preceding exercise estimated the effect of foreign markets, technological strength, 
and S&E capability on the probability and level of U.S. subsidiary R&D, by holding constant 
differences across industry sectors. However, we can expect important inter-industry differences 
in the balance of factors that determine the nature and extent of U.S. R&D overseas. The early 
observation that overseas laboratories are geared towards customizing products to foreign 
markets was developed with labor-saving consumer- and industrial goods in mind (Vernon 1966). 
Industries like oil, natural gas, minerals, and others have always found it viable to conduct a 
                                                     
14 Normalized coefficients measure changes in the outcome variable in response to a standard 
deviation change in the explanatory variable and are not reported here.  
15 F-tests for the absolute equality of coefficients confirmed that the impact of SEPUBS on 
USPATS were significantly different for the hurdle and count models.      
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portion of their research where the resources naturally occur. During the 1970s and 1980s, U.S. 
automobile, electrical, and electronics firms started research facilities in Germany and Japan 
undeterred by the scarce pool of skilled workers in those nations. Trends over the last decade 
have seen China and India emerge as attractive R&D destinations for U.S. industries ranging 
from chemicals to computers.  
TABLE 3 HERE 
 Table 3 captures the weight (percentage) of each U.S. industry in our overseas sales, 
R&D, and patenting data.  Out of total foreign sales of 4712 B$ by U.S. subsidiaries, the chemical 
industry accounted for 23%.  The importance of R&D in this industry is indicated by the heavier 
weight it carries in the R&D data.  Of the total 113 B$ of R&D expenditures by U.S. overseas 
subsidiaries, 36% was spent by the chemicals industry which also accounted for 35% of the 
nearly 72,500 patents assigned to U.S. overseas subsidiaries during the period.  The high 
propensity to patent in the IT industries (Hicks, et al. 2001) is suggested by the 19% share of 
R&D spent by the U.S. electrical, electronics, and computer based industry compared to their 
31% of patents abroad.   
 We formally test for inter-industry differences in the effect of the explanatory variables 
of equation (1), by estimating models for the eight different industrial sectors separately, instead 
of controlling for the effect of industries by allowing their intercepts to vary as we did previously. 
Since most of our identification came from the non-zero U.S. subsidiary patenting equation 
(estimated by the negative binomial part of the ZINB); we here report models with the positive 
count of U.S. subsidiary patents as the dependent variable. 
TABLE 4 HERE 
 Table 4 produces negative-binomial regression estimates with all industrial sectors 
pooled in column 1 (this establishes consistency of our modified model with the model and 
results discussed in section 4.2), and individually for the eight industries in columns 2-9.  All 
coefficients have the usual ceteris paribus interpretation. S&E publications strongly and directly 
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determine U.S. subsidiary patenting in the electrical, electronics and computers, transport, metals, 
and industrial machinery industry. Surprisingly, neither this, nor the technology strength variable 
predicts the patenting activity of U.S. subsidiaries in the chemical industry. The technological 
strength variable is a very strong predictor of U.S. subsidiary patenting in the oil, natural gas and 
mining industries whose immovable, naturally occurring resource base nurtures local as well as 
foreign owned innovative engineering capacity. 
5.0 Discussion and Conclusions 
This industry-level study examined the relative importance of foreign country factors – markets, 
technological strength, and S&E capability - in determining both the probability and extent of 
U.S. multinational R&D and patenting activities on their shores.  The striking aspect of our result 
is the significance of nations’ S&E capability for the intensity of U.S. patenting, over and above 
what can be explained by local market and technological strength variables.  We found the effect 
to be particularly significant in the relatively new electronics and computers industry, as well as 
in the traditional sectors of transport, metals, and industrial machinery.  We call this the S&E 
capability premium of nations.  Our results suggest that the importance of this premium increases 
with the level and sophistication of innovative activity carried out by U.S. industry (holding 
market and technology strength factors fixed).  
 There is evidence for both the old and the new in our study. We confirmed that the size of 
local markets strongly predict both firms’ engagement in and subsequent commitment to overseas 
R&D.  The novelty from this exercise is that while markets and technological strengths initially 
attract multinational enterprises to set up R&D activities, the growth of innovation as measured 
by U.S. patents invented abroad, is predicated on the country’s S&E capability base. While we 
cannot directly compare point estimates across regressions with different dependent variables, the 
significance of sales “within” the regressions was highest in predicting the probability of R&D, 
and decreased in predicting the level of R&D, the probability of patenting, and the level of 
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patenting, in that order.  S&E articles on the other hand, had the greatest impact on the level of 
patents and a negligible effect on influencing the establishment of U.S. R&D. 
 Our insight into the S&T capability premium of nations aligns with the findings of a 
recent survey by the Economist Intelligence Unit (EIU 2004).  The EIU interviewed 104 senior 
corporate executives reporting that MNCs now seek to establish and manage “global research 
networks” of geographically dispersed units that contribute more or less equally to the company’s 
research enterprise.  The desire to exploit highly skilled researchers wherever they are located is 
the key driver of this development.  In response to the EIU survey question on the main benefits 
of globalized R&D, the “global search for expertise” function showed an edge over traditional 
business factors such as reducing R&D costs and tailoring goods and services to particular 
markets.  It also trumped newer factors such as access to 24/7 global R&D processes and reduced 
time to market.  The survey concluded that combined with the emergence of world class 
technological capability in East Asian countries outside Japan, the global search for R&D talent is 
changing the nature and extent of MNC overseas R&D.   
That Asian S&T capability has rapidly strengthened in recent years is evident in science 
and technology indicators which show sharp increases in international journal literature sourced 
from Asian countries and in U.S. patents invented there (Hicks 2004).  The cases of India and 
China, and the contrasting experience of Western European nations serve well to illustrate the 
point.  In 1990, Europe accounted for nearly 70% of all U.S. overseas subsidiary patenting, while 
China and India together accounted for less than 0.1% of the amount.  Thirteen years later, 
Europe’s share had declined to 65% while that of China and India had increased to 2.3%. 
Considering the very small number of patents for India and China to start with, this translates into 
a huge growth, while from the initial large numbers for Europe, an even more striking decline. 
During the comparable period, China and India increased their S&E publication output from 
about 4.5% to 7.2% while Europe’s numbers hovered around half the total share of non-U.S. 
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articles. This aligns with the conventional notion of Europe’s technology strength and the recent 
focus on the potential of China and India’s vast S&E talent pools. 16 
 Several Asian nations, notably India and China, have long had substantial S&T 
capability.  However, this resource was relatively unproductive in their economies.  Why can we 
now view it as an S&T capability premium?  Key here may be the transformation wrought on 
communication by information technology.  Recall that the need for intense communication was 
always adduced in support of arguments that research must be kept at home.  Vernon speculated 
on a type of firm he called a “global scanner” able to search the world for the best and brightest 
and take advantage of resources wherever they were found.  The factor limiting his vision to 
fantasy was, he said, the high cost of acquiring and processing information (Vernon 1979).  Now 
that global communication is so much easier, faster and cheaper, this fundamental limit on 
managing and integrating geographically dispersed R&D has considerably diminished.  
That multinational R&D is evolving in response to shifts in communication technology 
and strengthening national R&D capability should not be not surprising.  Scholars have tracked 
foreign subsidiary R&D for four decades, beginning with Vernon’s work in the 1960s.  In the 
1970s, Vernon pointed out that multinational’s foreign R&D evolves recursively (becoming 
easier as firms gain experience abroad) and in response to environmental factors (changes in the 
sophistication of markets for example).  Work since can be seen as a series of snapshots that 
when taken together speak to the evolution of MNCs’ overseas R&D over time.  Table 5 
summarizes this.   
TABLE 5 HERE 
                                                     
16 Our example is consistent with the diminishing returns to investment argument. Countries like 
Europe and Japan, with nowhere near the human capital endowments of China or India, may 
already be operating in the leveled-off part of the R&D productivity equation. This idea is 
consistent with Scherer (1997) and Helpman (2002).  
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The first theories of globalization, up to about 1980, suggested that R&D followed 
manufacturing to adapt products and processes to local markets.  Scholars added the listening 
post functions to account for the increase and variety of overseas R&D during the 1980s and early 
90s.  In both models, overseas R&D sites were auxiliary outposts, subservient to home R&D 
laboratories.  Recently scholars have focused on taxonomies of innovative roles played by MNC 
laboratories (see for example, Almeida and Phene 2004).  Birkinshaw and Hood (2000) for 
example, argue that subsidiaries play two distinct roles. “Product specialist” subsidiaries have 
limited expertise and focus, while those with a “world mandate” have broad responsibilities, 
considerable autonomy within the MNC, and extensive capabilities in R&D.  Our table responds 
to this development by dividing subsidiary innovative capability into three categories of 
increasing sophistication – incremental innovation, multi-technology product innovation and use-
inspired basic research.  Although basic research may not be under discussion at the moment, this 
projection into the future would seem to complete the natural progression as it has developed thus 
far.  We know such research exists in Europe, where IBM’s Zurich laboratory discovered high 
temperature superconductivity a few decades ago.  Hence, we suspect that laboratories of 
different firms, at different times and in different places will be found in each of these categories.  
What changes over time is that we find more laboratories of leading firms, in more places at more 
advanced levels.  Our results lead us to argue that the scientific capability of countries will be a 
critical factor in deciding how innovative their MNC laboratories become.  
Our paper has not explicitly treated factors which influence the decision to locate R&D at 
home (U.S.) or in a foreign country, yet we can pose the question: how much U.S. subsidiary 
R&D abroad can be attributed to a shifting of existing activity from home to foreign locations?  
While it is hard to tease out these effects, our data (graphed in FIGURE 2) suggest that the extent 
of and growth in innovative activity (patents and R&D) of U.S. MNCs abroad, trails employment, 
investment (fixed assets), and sales abroad.  This is in line with the work of early economists who 
argue that R&D tends to be “sticky” and innovation still represents a case of “non-globalization”.  
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FIGURE 2 HERE 
 However, our result that when growing beyond the necessity to serve overseas markets, 
innovation intensity follows S&E capacity calls for a reexamination of the received wisdom.  
Concerns are already being raised about the depleting pool of U.S. scientists and researchers and 
the vast endowments of countries like China and India in this regard.  Increasingly footloose and 
behaving like Vernon’s “global scanners.” similar factors can be expected to influence the 
decisions of American firms to locate R&D in one of two overseas locations and to locate R&D 
at home or abroad.  This threat, and indeed the spirit of our results, is succinctly captured in the 
words of Craig Barrett, the former chief of Intel Corporation: “If the world's best engineers are 
produced in India or Singapore, that is where our companies will go.  This is the reality in the 
modern world. We locate facilities where we can find or import talent” (Times of India 2005). 
Technological change is a highly dynamic process that may quickly relocate to take advantage of 
optimum conditions for growth.           
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TABLE 1: COUNTRY-LEVEL DESCRIPTIVES 
 
Variable Description 1991-2002 1991 2002 
    Mean Median Mean Median Mean Median 
1506 175 84 4 253 36USPAT Patents assigned to US subsidiaries [3488.9] [43] [206.7] [40] [538.1] [38]
2450 187 150 3 366 34USRAND R&D by US subsidiaries in M$ [5867.8] [43] [404.2] [40] [786.7] [38]
100.1 15.4 8.1 0.8 10.7 2.3SALES Local sales by US subsidiaries in B$ [193.53] [43] [16.99] [40] [20.04] [38]
7980 469 609 11 1196 98
PATENT Patents assigned to 
overseas- firms [26799.1] [43] [2064.1] [40] [3651.3] [38]
86.9 28.8 6.6 2.4 10.5 5.0SEPUB*** S&E publication of overseas nations [133.68] [43] [10.51] [40] [13.76] [38]
* Standard Errors 
** Number of observations (countries) 
***Latest year for SEPUB is 2001 
  
 
TABLE 2: REGRESSION RESULTS 
 
  Tobit with Moffit decomposition Zero-inflated neg-binomial  
  
Marginal Effects at 
Observed Censoring Rate 
Zero-inflated 
logit Neg-bin  





uncensored Pr(USPAT=0) USPAT(#) 
SALES 28.04 12.63 0.06 -0.57 1.08 
 [19.91]***   [2.41]** [8.12]*** 
SEPUB 3.03 1.36 0.01 -0.05 1.05 
 [5.80]***   [1.09] [14.34]*** 
PATENT 2.20 0.99 0.00 -25.84 1.02 
 [2.78]***   [5.25]*** [3.22]*** 
YEAR DUMMIES ***   ***  
REGION DUMMIES ***   ***  
TECH DUMMIES ***   ***  
CONSTANT -462.77     
 [13.55]***     
OBSERVATIONS 1817   1817 1817 
DEGREE OF 
FREEDOM 25   25  
LOG LIKLIHOOD -7863.54   -4936.22  
PROB > CHI2 0   0  
Observation summary for Tobit: 650  left-censored at RAND<=0; 1167 uncensored. 
Observation summary for ZINB: 747 with USPAT<=0; 1070 nonzero observations. 
Absolute value of z statistics in brackets 
* significant at 10%; ** significant at 5%; *** significant at 1% 
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TABLE 3: WEIGHT (%) OF U.S INDUSTRY IN VARIOUS OVERSEAS ACTIVITIES  
 
 INDUSTRY SALES R AND D PATENTS 
Chemicals 23.4 35.8 34.6 
Oil, Minerals, and Natural Gas 15.1 0.3 1.6 
Transportation & equipment 14.5 30.6 6 
Food 12.5 2.5 1 
Computers, Electrical & electronics 10.9 18.8 30.8 
Industrial Machinery 10.9 10.5 14.5 
Other 8.4 0.1 10.3 
Primary and Fabricated metals 4.3 1.4 1.3 
 
 
TABLE 4: REGRESSION RESUTS BY INDUSTRY  
 







  USPAT USPAT USPAT USPAT USPAT 
SALES 1.08 1.27 1.21 1.07 1.06 
 [6.61]*** [7.28]*** [5.23]*** [4.68]*** [2.46]** 
SEPUB 1.047 0.999 1.061 1.066 1.06 
 [13.06]*** [0.13] [11.98]*** [6.37]*** [7.56]*** 
PATENT 1.03 1.01 1.00 1.11 1.08 
 [3.15]*** [0.73] [0.08] [3.38]*** [5.28]*** 
YEAR DUMMIES ***     
REGION DUMMIES ***     
TECH DUMMIES ***     
OBSERVATIONS 1070 254 233 82 177 
DEGREE OF 
FREEDOM 25 18 18 18 18 
LOG LIKLIHOOD -4440.83 -1164.15 -1038.39 -284.66 -714.51 
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minerals Food  Others 
  USPAT USPAT USPAT USPAT 
SALES 0.96 1.04 1.03 1.03 
 [0.50] [3.47]*** [0.69] [2.46]** 
SEPUB 1.05 1.00 1.00 1.05 
 [4.43]*** [0.20] [0.12] [4.62]*** 
PATENT 1.36 32.47 7.80 1.04 
 [3.73]*** [3.33]*** [3.45]*** [1.31] 
YEAR DUMMIES     
REGION DUMMIES    
OBSERVATIONS 97 64 89 74 
DEGREE OF 
FREEDOM 18 18 18 18 
LOG LIKLIHOOD -263.80 -189.84 -224.95 -315.42 
PROB > CHI2 0 0 0 0 
Robust z statistics in brackets  
* significant at 10%; ** significant at 5%; *** significant at 1%  
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FIGURE 1: OBSERVED & PREDICTED VALUES OF USPATENT COUNTS FROM 
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